Inventor

GILLIES STEPHEN D

US64 patents

⚠️ This page may combine multiple inventors who share the name “GILLIES STEPHEN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GILLIES STEPHEN D

MERCK PATENT GMBH

DNA encoding IL-2 fusion proteins with modulated selectivity

Enhancing the circulating half-life of antibody-based fusion proteins

Fc-interferon-beta fusion proteins

Methods of targeting multiple cytokines

Anti-cancer antibodies with reduced complement fixation

Immunocytokine sequences and uses thereof

IL-7 variants with reduced immunogenicity

Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation

IL-7 fusion proteins

Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens

Fc-erythropoietin fusion protein with improved pharmacokinetics

Anti-cancer antibodies with reduced complement fixation

Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation

Methods of using Fc-cytokine fusion proteins

Reducing the immunogenicity of fusion proteins

Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents

EMD LEXIGEN RES CT CORP

Expression technology for proteins containing a hybrid isotype antibody moiety

Multiple cytokine protein complexes

Enhancing the circulating half-life of antibody-based fusion proteins

Reducing the immunogenicity of fusion proteins

IL-2 fusion proteins with modulated selectivity

Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation

Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation

Multiple cytokine protein complexes

Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens

Immunocytokine sequences and uses thereof

Recombinant tumor specific antibody and use thereof

IL-7 fusion proteins

Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies

KYMAB LTD

Antibodies and immunocytokines

Antibodies and immunocytokines

Antibodies and immunocytokines

Anti-ICOS antibodies

FUJI IMMUNOPHARMACEUTICALS COR

Expression and export technology of proteins as immunofusins

Expression and export technology of proteins as immunofusins

Inhibition of IL-12-induced IFN-γ synthesis by specific bis-phenol compounds as a method of immune modulation

GILLIES STEPHEN D

Proteins comprising an IgG2 domain

Anti-cancer antibodies with reduced complement fixation

Stabilization of Fc-interferon-beta fusion proteins

(unassigned)

Recombinant antibody cytokine fusion proteins

Vector and method for achieving high level of expression in eukaryotic cells

EMD SERONO RES CT INC

Enhancing the circulating half-life of antibody-based fusion proteins

Cancer treatments including administering IL-2 fusion proteins with modulated selectivity

ABBOTT BIOTECH INC

Method of producing engineered binding proteins

Method of producing fusion proteins

CARR FRANCIS JOSEPH

CD20-binding polypeptide compositions for treating autoimmune disease

CD20-binding polypeptide compositions and methods

MASSACHUSETTS INST TECHNOLOGY

Enhanced production of proteinaceous materials in eucaryotic cells

SCRIPPS RESEARCH INST

Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies

LAUDER SCOTT

IL-7 fusion proteins